HEPACAM and myeloid sarcoma: Indeed, EBNA1 and, in particular, its domain (aa385–420) that elicits antibodies associated with the biggest increase in MS risk [40] or the neighboring aa431–440 sequence provides homologies to several CNS autoantigens, including GlialCAM and anoctamin [45,46].